PEGPH20, Gemicitabine and Nab-Paclitaxel for Pancreatic Ductal Adenocarcinoma
Clinical trial NCT02487277 · TERMINATED
Trial details
- NCT number
- NCT02487277
- Sponsor
- Andrew Ko
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-14
- Primary completion
- 2018-05-18
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.